NewslettersHematopoiesis NewsUncategorizedFenofibrate Increases Circulating Hematopoietic Stem Cells in People with Diabetic Retinopathy: A Randomized, Placebo-Controlled TrialBy Justin.choi - August 10, 2021017The authors investigated whether fenofibrate increased circulating hematopoietic stem/progenitor cells (HSPCs). When compared with placebo, fenofibrate significantly increased levels of HSPCs expressing CD34 and/or CD133.[Diabetologia] 7992332 {7992332:U7KJZ6IM} apa 50 1 165470 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/AbstractGraphical Abstract